- Full Time
with a special interest in Stem Cell Transplantation and Cellular Therapies
The Christie Foundation Trust is seeking to appoint a new substantive Consultant Haematologist with a special interest in Stem Cell Transplantation and Cellular Therapies
The stem cell transplant program at the Christie was established in 1982 since when it has undertaken almost 3000 procedures.
The department currently performs 120-160 transplants (autologous and allogeneic including cord blood and haplo-identical donors) per year with a 30-40% increase in activity 2008-18.
The program has been fully JACIE accredited since 2009 and will be due for second full re-inspection in 2020. In 2018, the Christie was selected as one of 7 first wave UK centres for delivery of CAR-T therapy.
The unit is fully accredited for treatment with JACIE and the first patients are being treated in 2019.
This is a full-time (10PA) new position funded as part of a comprehensive business case approved in 2019 with a primary responsibility for stem cell transplantation and cellular therapies and to support the projected continued increase in activity.
The Department of Haematology currently comprises 9 Consultant Haematologists (6 NHS substantive, 1 NHS locum and 2 Clinical Academic/Honorary Consultant) together with a large team of junior medical staff and specialist nurses and works closely with the Lymphoma team of 6 Consultant Medical and Clinical Oncologists.
The department is a BCSH level 3 tertiary centre and receives referrals from across the North West of England and North Wales for treatment of patients with haematological malignancies and for stem cell transplantation. Inpatients are treated in a purpose built 31 bed facility (opened 2014) which is co-located with the regional teenage and young adult (TYA) service and adjacent to an 8-bay ambulatory care unit opened in 2019.
Alongside the clinical service, the department has an outstanding research record and the post presents also opportunities for clinical and translational research working with colleagues in the Manchester Cancer Research Centre (MCRC - co-located on The Christie Campus). In 2017, the Christie led a successful bid for £6.9 million funding from Innovate UK to develop the iMATCH program (one of 3 successful awards nationally) which is a collaborative venture between the Christie, University of Manchester Foundation Trust, the University of Manchester and 7 industry partners to develop infrastructure and capacity for advanced therapeutic (including CAR-T cells) clinical trials.
Applicants should have CCT or be on the GMC’s Specialist Register. Applicants who are within six months of obtaining their CCT on the date of the AAC may also apply. Applicants will be expected to demonstrate excellent communication skills, to a professional standard, in spoken and written English.
Where equivalent qualifications or experience are being offered, it is essential that candidates should provide confirmation of this from the relevant College or Faculty in the United Kingdom and attach the confirmation to your application.
Applicants must have significant experience in the diagnosis and management of haematological malignancies and allogeneic stem cell transplantation.
When applying please remember to include your CCT date in the membership of professional bodies section of the online application form, which is where you must also record your GMC number.
Interested applicants are encouraged to contact Dr Adrian Bloor (Clinical Director) via PA Tracy Blinkhorn (0161 446 3869).
A job description and information pack is available from NHS Jobs by clicking the apply button.
Closing date for applications is 26th June 2019